AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Havranek, EP
Citation: Ep. Havranek, Editorial comment - Catching the missed opportunities in heart failure, J CARD FAIL, 7(3), 2001, pp. 239-240

Authors: Havranek, EP Lapuerta, P Simon, TA L'Italien, G Block, AJ Rouleau, JL
Citation: Ep. Havranek et al., A health perception score predicts cardiac events in patients with heart failure: Results from the IMPRESS trial, J CARD FAIL, 7(2), 2001, pp. 153-157

Authors: Masoudi, FA Havranek, EP
Citation: Fa. Masoudi et Ep. Havranek, Race and responsiveness to drugs for heart failure., N ENG J MED, 345(10), 2001, pp. 767-767

Authors: Sauaia, A Ralston, D Schluter, WW Marciniak, TA Havranek, EP Dunn, TR
Citation: A. Sauaia et al., Influencing care in acute myocardial infarction: A randomized trial comparing 2 types of intervention, AM J MED QU, 15(5), 2000, pp. 197-206

Authors: Krumholz, HM Brass, LM Every, NR Spertus, JA Bazzarre, T Cohen, DJ Hlatky, MA Peterson, ED Radford, MJ Weintraub, WS Every, NR Cannon, CP Ellerbeck, EF McNeil, BJ Peterson, ED Radford, MJ Ryan, TJ Smith, SC Spertus, JA Krumholz, HM Baker, DW Ashton, CM Dunbar, SB Friesinger, GC Havranek, EP Hlatky, MA Konstam, M Ordin, DL Pina, IL Pitt, B Spertus, JA Spertus, JA DeLong, ER Eagle, RA Normand, SL Mark, DB McAllister, BD Thomas, JW Weintraub, WS Brass, LM Duncan, PW Goldstein, LB Gorelick, PB Hinchey, JA Matchar, DB Nilasena, D Wennberg, D Williams, LS Wolf, PA
Citation: Hm. Krumholz et al., Measuring and improving quality of care - A report from the American HeartAssociation/American College of Cardiology First Scientific Forum on Assessment of healthcare quality in cardiovascular disease and stroke, STROKE, 31(4), 2000, pp. 1002-1012

Authors: Krumholz, HM Baker, DW Ashton, CM Dunbar, SB Friesinger, GC Havranek, EP Hlatky, MA Konstam, M Ordin, DL Pina, IL Pitt, B Spertus, JA
Citation: Hm. Krumholz et al., Evaluating quality of care for patients with heart failure (vol 101, e122,2000), CIRCULATION, 101(25), 2000, pp. 2995-2995

Authors: Krumholz, HM Baker, DW Ashton, CM Dunbar, SB Friesinger, GC Havranek, EP Hlatky, MA Konstam, M Ordin, DL Pina, IL Pitt, B Spertus, JA
Citation: Hm. Krumholz et al., Evaluating quality of care for patients with heart failure, CIRCULATION, 101(12), 2000, pp. E122-E140

Authors: Krumholz, HM Brass, LM Every, NR Spertus, JA Bazzarre, T Cohen, DJ Hlatky, MA Peterson, ED Radford, MJ Weintraub, WS Cannon, CP Ellerbeck, EF McNeil, BJ Peterson, ED Radford, MJ Ryan, TJ Smith, SC Baker, DW Ashton, CM Dunbar, SB Friesinger, GC Havranek, EP Hlatky, MA Konstam, M Ordin, DL Pina, IL Pitt, B DeLong, ER Eagle, KA Normand, SL Mark, DB McAllister, BD Thomas, JW Weintraub, WS Brass, LM Duncan, PW Goldstein, LB Gorelick, PB Hinchey, JA Matchar, DB Nilasena, D Wennberg, D Williams, LS Wolf, PA
Citation: Hm. Krumholz et al., Measuring and improving quality of care - A report from the American HeartAssociation/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in cardiovascular disease and stroke, CIRCULATION, 101(12), 2000, pp. 1483-1493

Authors: Havranek, EP McGovern, KM Weinberger, J Brocato, A Lowes, BD Abraham, WT
Citation: Ep. Havranek et al., Patient preferences for heart failure treatment: Utilities are valid measures of health-related quality of life in heart failure, J CARD FAIL, 5(2), 1999, pp. 85-91

Authors: Estacio, RO Jeffers, BW Havranek, EP Krick, D Raynolds, M Schrier, RW
Citation: Ro. Estacio et al., Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus, AM J HYPERT, 12(6), 1999, pp. 637-642

Authors: Havranek, EP Thomas, I Smith, WB Ponce, GA Bilsker, M Munger, MA Wolf, RA
Citation: Ep. Havranek et al., Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure, J AM COL C, 33(5), 1999, pp. 1174-1181

Authors: Havranek, EP Ware, MG Lowes, BD
Citation: Ep. Havranek et al., Prevalence of depression in congestive heart failure, AM J CARD, 84(3), 1999, pp. 348

Authors: Havranek, EP
Citation: Ep. Havranek, Hormone replacement therapy and risk of heart disease - In Reply, AM FAM PHYS, 60(8), 1999, pp. 2234

Authors: Havranek, EP
Citation: Ep. Havranek, Primary prevention of CHD: Nine ways to reduce risk, AM FAM PHYS, 59(6), 1999, pp. 1455-1463
Risultati: 1-14 |